Latest
Govineer Solutions Lands TA Investment as AI Targets Local Government InfrastructureGovineer Solutions Lands TA Investment as AI Targets Local Government Infrastructure|9amHealth Raises $26M Series B as Chronic Care Economics Shift9amHealth Raises $26M Series B as Chronic Care Economics Shift|QuartzBio Secures Eir Partners Investment to Expand Clinical Trial IntelligenceQuartzBio Secures Eir Partners Investment to Expand Clinical Trial Intelligence|Oishii Raises $150M Series C as Vertical Farming Grows Up FastOishii Raises $150M Series C as Vertical Farming Grows Up Fast|DataMission.ai Raises $1M Seed to Modernize the Software Layer Running Local GovernmentDataMission.ai Raises $1M Seed to Modernize the Software Layer Running Local Government|Monaco Raises $50M Series B as AI Sales Infrastructure Gets Rebuilt From ScratchMonaco Raises $50M Series B as AI Sales Infrastructure Gets Rebuilt From Scratch|cultivate(MD) Deploys Capital Across 4 Medtech Companies as Precision Medicine Infrastructure Acceleratescultivate(MD) Deploys Capital Across 4 Medtech Companies as Precision Medicine Infrastructure Accelerates|Anduril Industries Raises $5B Series H as Defense Tech Enters Its Factory EraAnduril Industries Raises $5B Series H as Defense Tech Enters Its Factory Era|Top Down Ventures Closes $28M Fund I as MSP Software Quietly Becomes Venture Capital’s Most Underestimated Infrastructure BetTop Down Ventures Closes $28M Fund I as MSP Software Quietly Becomes Venture Capital’s Most Underestimated Infrastructure Bet|EnsoData Secures Growth Capital as Sleep Medicine Becomes an Infrastructure ProblemEnsoData Secures Growth Capital as Sleep Medicine Becomes an Infrastructure Problem|Govineer Solutions Lands TA Investment as AI Targets Local Government InfrastructureGovineer Solutions Lands TA Investment as AI Targets Local Government Infrastructure|9amHealth Raises $26M Series B as Chronic Care Economics Shift9amHealth Raises $26M Series B as Chronic Care Economics Shift|QuartzBio Secures Eir Partners Investment to Expand Clinical Trial IntelligenceQuartzBio Secures Eir Partners Investment to Expand Clinical Trial Intelligence|Oishii Raises $150M Series C as Vertical Farming Grows Up FastOishii Raises $150M Series C as Vertical Farming Grows Up Fast|DataMission.ai Raises $1M Seed to Modernize the Software Layer Running Local GovernmentDataMission.ai Raises $1M Seed to Modernize the Software Layer Running Local Government|Monaco Raises $50M Series B as AI Sales Infrastructure Gets Rebuilt From ScratchMonaco Raises $50M Series B as AI Sales Infrastructure Gets Rebuilt From Scratch|cultivate(MD) Deploys Capital Across 4 Medtech Companies as Precision Medicine Infrastructure Acceleratescultivate(MD) Deploys Capital Across 4 Medtech Companies as Precision Medicine Infrastructure Accelerates|Anduril Industries Raises $5B Series H as Defense Tech Enters Its Factory EraAnduril Industries Raises $5B Series H as Defense Tech Enters Its Factory Era|Top Down Ventures Closes $28M Fund I as MSP Software Quietly Becomes Venture Capital’s Most Underestimated Infrastructure BetTop Down Ventures Closes $28M Fund I as MSP Software Quietly Becomes Venture Capital’s Most Underestimated Infrastructure Bet|EnsoData Secures Growth Capital as Sleep Medicine Becomes an Infrastructure ProblemEnsoData Secures Growth Capital as Sleep Medicine Becomes an Infrastructure Problem
Back to articles

Baird Capital Raises $450M Global Fund III to Invest in B2B Technology and Services Companies

Money talks, but $450M doesn’t just talk, it walks into the room, takes your seat, and asks better questions than you came prepared with. Baird Capital just closed its third Global Fund at a hard cap of $450M, and the signal is loud even if the tone stays buttoned up. This is growth equity and buyout capital aimed straight at B2B technology and services companies sitting in that sweet spot most people overlook. Not too early, not too bloated. Revenues between $10M–$100M. Checks landing between $25M–$75M. Enough fuel to scale, not enough to lose discipline.

Credit where it’s due. Gordon Pan, President of Baird Capital, and the broader leadership team didn’t just raise a bigger fund. They pulled in commitments from every prior anchor investor and still had demand left standing outside. That’s not luck. That’s pattern recognition meeting execution over decades. More than 30+ years in the game tends to sharpen your aim.

And they’re not wasting time posing for the press shot. 3 investments are already in motion. EvoluteIQ bringing native AI into the workflow conversation. Rapid Energy solving very real, very unsexy problems around temperature control when it matters most. autoLOTO locking down safety compliance with software that actually understands the job site. Different verticals, same theme. Practical tech. Revenue attached. Problems that don’t disappear in a downturn.

There’s a lesson buried in here for operators chasing capital. Baird isn’t hunting hype cycles. They’re backing founder-led businesses that already figured out how to sell. The kind where the product earns its keep before the pitch deck starts making promises. You want institutional money at this level, you show traction, you show discipline, and you show you know exactly where the next dollar goes.

Chicago to London, this fund keeps the focus tight. U.S. and U.K. markets. B2B only. No wandering off into whatever trend is getting the most likes this quarter. That restraint is the strategy. And in a market that’s been drunk on excess more than once, restraint suddenly looks like genius.